Yiling Pharmaceuticals will set up subsidiary for genetic testing, Ridge Biological Pharmaceutical Co.

Investment from Yiling will be 15 Mill. Yuan, and the focus will be on prognosis for various cancer risks.

CAS news release, Oct. 20, 2014